Answers are grounded in this paper and cite their sources.
These data suggest that the tailored early intervention is appropriate and clinically effective for the treatment of depressive symptoms in those newly diagnosed with MS. A larger RCT comparing the CBT intervention with an active comparative treatment with longer term follow-up and cost effectiveness analyses is warranted. The pilot trial has been retrospectively registered on 28/04/2016 with the ISRCTN registry (trial ID ISRCTN10423371).
No takes yet. Share an insight, caveat, or question.
Kiropoulos et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: